{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-045804","form_type":"8-K","ticker":"CTNM","cik":"0001855175","company_name":"Contineum Therapeutics, Inc.","filed_at":"2026-06-26T20:48:50+00:00","discovered_at":"2026-06-26T20:50:00.372760+00:00","generated_at":"2026-06-26T20:50:11.784503+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Contineum Therapeutics stockholders elect three Class II directors at 2026 annual meeting","bullets":["Three Class II directors elected: Evert Schimmelpennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.","Broker non-votes of 6,133,812 shares on each director election.","Ratification of Ernst & Young LLP as independent auditor for FY 2026: 28,021,047 votes for, 16,104 against.","Record date April 27, 2026; 32,723,877 shares of Class A common stock outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-045804","json":"https://secwatch.observer/filing/0001628280-26-045804.json","markdown":"https://secwatch.observer/filing/0001628280-26-045804.md","text":"https://secwatch.observer/filing/0001628280-26-045804.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/0001628280-26-045804-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/ctnm-20260626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T20:50:11.784503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}